Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family

被引:0
作者
Ciyu Yang
Margaret Sheehan
Ester Borras
Karen Cadoo
Kenneth Offit
Liying Zhang
机构
[1] Memorial Sloan Kettering Cancer Center,Departments of Pathology
[2] Memorial Sloan Kettering Cancer Center,Departments of Medicine
[3] University of California at Los Angeles (UCLA),Department of Pathology and Laboratory Medicine, David Geffen School of Medicine
来源
Familial Cancer | 2020年 / 19卷
关键词
MLH1; Germline; c.678-3T>A; Lynch syndrome; Splice site variant;
D O I
暂无
中图分类号
学科分类号
摘要
Germline mutations in the DNA mismatch repair (MMR) genes cause Lynch syndrome. Classification and interpretation of intronic variants, especially those outside the consensus ± 1 ~ 2 splice sites are challenging as it is uncertain whether such variants would affect splicing accuracy and efficiency. The assessment of the pathogenicity of splice site variants in MLH1 is further complicated by the various isoforms due to alternative splicing. In this report, we describe a 42-year-old female with Lynch syndrome who carries a germline variant, MLH1 c.678-3T>A, in the splice acceptor site of intron 8. Functional studies and semiquantitative analysis demonstrated that this variant causes a significant increase in the transcripts with exon 9 or exon 9 and 10 deletions, which presumably leads to premature protein truncation or abnormal protein. In addition, we also observed MSI-H and loss of MLH1 by IHC in patient’s tumor tissue. This variant also segregated with Lynch Syndrome related cancers in three affected family members. Based on these evidence, the MLH1 c.678-3T>A variant is considered pathogenic.
引用
收藏
页码:315 / 322
页数:7
相关论文
共 261 条
[1]  
Goecke T(2006)Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium J Clin Oncol 24 4285-4292
[2]  
Schulmann K(2005)Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)] Fam Cancer 4 219-225
[3]  
Engel C(2014)The genetic basis of Lynch syndrome and its implications for clinical practice and risk management Appl Clin Genet 7 147-158
[4]  
Holinski-Feder E(2016)Update on hereditary colorectal cancer Anticancer Res 36 4399-4405
[5]  
Pagenstecher C(2003)Hereditary colorectal cancer N Engl J Med 348 919-932
[6]  
Schackert HK(2008)The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside Fam Cancer 7 41-52
[7]  
Kloor M(2004)Mutations associated with HNPCC predisposition—update of ICG-HNPCC/INSiGHT mutation database Dis Mark 20 269-276
[8]  
Kunstmann E(2015)A review of mismatch repair gene transcripts: issues for interpretation of mRNA splicing assays Clin Genet 87 100-108
[9]  
Vogelsang H(2014)A multi-disciplinary cancer program enhances hereditary colorectal cancer detection Am J Digest Dis 1 62-66
[10]  
Keller G(2015)Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Genet Med 17 405-424